News | 05 August 2012
This week, ten Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an ?A? (?strong buy?) or ?B? overall (?buy?). Sangamo BioSciences' (NASDAQ:SGMO) grade is moving up to a B (?buy?) this week from last week ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)